BMS Revs R&D Engine To Advance 10 New Drug Candidates Annually
Speed, Quality, Productivity Drive Research Efforts
Bristol aims to bring more drugs into the clinic as fast as possible without compromising on quality, with many novel molecules emerging from its productive protein degradation and cell therapy platforms.